MarketBeat on MSN
Akebia Therapeutics sees Vafseo uptake rising as access and pipeline milestones near
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results